Related Experiment Video
Updated: May 9, 2026

Dual Test Gas Pulmonary Diffusing Capacity Measurement During Exercise in Humans Using the Single-Breath Method
Published on: February 2, 2024
Pulmonary manifestations in a patient with transaldolase deficiency
Nada Jassim1, Mohammed Alghaihab, Suhail Al Saleh
1Department of Pediatrics MC 1510, King Abdulaziz Medical City, King Fahad National Guard Hospital, 22490, Riyadh, 11426, Saudi Arabia.
Abstract:
Transaldolase deficiency is a newly recognized metabolic disorder. It is an autosomal recessive genetic disease (OMIM #606003). The effects of the defect in the TALDO gene are pleiotropic with a clinical presentation of growth retardation, dysmorphic features, cutis laxa, congenital heart disease, hepatosplenomegaly, pancytopenia, and bleeding tendencies. This is the first report of a child who was diagnosed at birth with transaldolase deficiency who subsequently developed hepatopulmonary syndrome.
Related Concept Videos
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Atelectasis II: Pathophysiology
Chronic Obstructive Pulmonary Disease II: Emphysema
Heart Failure III: Clinical Manifestations
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
